Biopharmaceuticals and biotechnology medicines: an issue of nomenclature.
Over the past two decades terms such as 'biopharmaceuticals' and 'biotechnology medicines' have crept into the pharmaceutical vocabulary. Such terms often have different meanings for different people and it is perhaps time that they were more formally defined.
Walsh
Gary
G
Industrial Biochemistry Program, University of Limerick, Limerick, Ireland. gary.walsh@ul.ie
D000911:Antibodies, Monoclonal / Q000145:classification; D001709:Biotechnology / Q000592:standards*; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards; D006801:Humans; D010455:Peptides / Q000145:classification; D004364:Pharmaceutical Preparations / Q000145:classification* / Q000592:standards; D009626:Terminology as Topic; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
D000911:Antibodies, Monoclonal; D010455:Peptides; D004364:Pharmaceutical Preparations